Correlation Between Eledon Pharmaceuticals and Alto Neuroscience,

Can any of the company-specific risk be diversified away by investing in both Eledon Pharmaceuticals and Alto Neuroscience, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eledon Pharmaceuticals and Alto Neuroscience, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eledon Pharmaceuticals and Alto Neuroscience,, you can compare the effects of market volatilities on Eledon Pharmaceuticals and Alto Neuroscience, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eledon Pharmaceuticals with a short position of Alto Neuroscience,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eledon Pharmaceuticals and Alto Neuroscience,.

Diversification Opportunities for Eledon Pharmaceuticals and Alto Neuroscience,

0.52

Correlation Coefficient

Eledon Pharmaceuticals  Alto Neuroscience,

Very weak diversification

The 3 months correlation between Eledon and Alto is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Eledon Pharmaceuticals and Alto Neuroscience, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alto Neuroscience, and Eledon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eledon Pharmaceuticals are associated (or correlated) with Alto Neuroscience,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alto Neuroscience, has no effect on the direction of Eledon Pharmaceuticals i.e., Eledon Pharmaceuticals and Alto Neuroscience, go up and down completely randomly.

Pair Corralation between Eledon Pharmaceuticals and Alto Neuroscience,

Given the investment horizon of 90 days Eledon Pharmaceuticals is expected to generate 0.69 times more return on investment than Alto Neuroscience,. However, Eledon Pharmaceuticals is 1.44 times less risky than Alto Neuroscience,. It trades about -0.09 of its potential returns per unit of risk. Alto Neuroscience, is currently generating about -0.16 per unit of risk. If you would invest  435.00  in Eledon Pharmaceuticals on December 27, 2024 and sell it today you would lose (94.00) from holding Eledon Pharmaceuticals or give up 21.61% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Eledon Pharmaceuticals  vs.  Alto Neuroscience,

Eledon Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Eledon Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Alto Neuroscience,

Risk-Adjusted Performance

Very Weak

Over the last 90 days Alto Neuroscience, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Eledon Pharmaceuticals and Alto Neuroscience,

The main advantage of trading using opposite Eledon Pharmaceuticals and Alto Neuroscience, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eledon Pharmaceuticals position performs unexpectedly, Alto Neuroscience, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alto Neuroscience, will offset losses from the drop in Alto Neuroscience,'s long position.

The idea behind Eledon Pharmaceuticals and Alto Neuroscience, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.